| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33c922e05f6133b7d72dbb849d77487d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate |
2016-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcb5fd05ecd5ad3a561e4178227f90bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5842055074654be59d2d7e312b3b310
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abfc462ed1a527b87459c0bd3677fc9d |
| publicationDate |
2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MA-42361-A1 |
| titleOfInvention |
Pharmaceutical composition containing, as active ingredient, a pharmaceutically acceptable derivative or salt of 7-azaindolin-2-one |
| abstract |
The present invention relates to a pharmaceutically acceptable derivative or salt of 7 azaindolin-2-one. Said derivative or pharmaceutically acceptable salt of 7-azaindolin-2-one can be advantageously used as a medicinal substance to inhibit the growth of cancer and cancerous metastases. |
| priorityDate |
2015-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |